Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation

G Calabrese, C Molzahn, T Mayor - Journal of Biological Chemistry, 2022 - ASBMB
The accumulation of protein inclusions is linked to many neurodegenerative diseases that
typically develop in older individuals, due to a combination of genetic and environmental …

Molecular chaperones: a double-edged sword in neurodegenerative diseases

J Tittelmeier, E Nachman… - Frontiers in aging …, 2020 - frontiersin.org
Aberrant accumulation of misfolded proteins into amyloid deposits is a hallmark in many age-
related neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's …

Modulation of Alzheimer's Disease Aβ40 Fibril Polymorphism by the small heat shock protein αB-Crystallin

N Rodina, S Hornung, R Sarkar… - Journal of the …, 2024 - ACS Publications
Deposition of amyloid plaques in the brains of Alzheimer's disease (AD) patients is a
hallmark of the disease. AD plaques consist primarily of the beta-amyloid (Aβ) peptide but …

Secreted chaperones in neurodegeneration

K Chaplot, TS Jarvela, I Lindberg - Frontiers in aging neuroscience, 2020 - frontiersin.org
Protein homeostasis, or proteostasis, is a combination of cellular processes that govern
protein quality control, namely, protein translation, folding, processing, and degradation …

Unveiling the structural and functional consequences of the p. D109G pathogenic mutation in human αB-Crystallin responsible for restrictive cardiomyopathy and …

MH Jafari, MB Shahsavani, M Hoshino, J Hong… - International Journal of …, 2024 - Elsevier
Abstract αB-Crystallin (αB-Cry) is expressed in many tissues, and mutations in this protein
are linked to various diseases, including cataracts, Alzheimer's disease, Parkinson's …

Targeting chaperone/Co-chaperone interactions with small molecules: a novel approach to tackle neurodegenerative diseases

L Wang, L Bergkvist, R Kumar, B Winblad, PF Pavlov - Cells, 2021 - mdpi.com
The dysfunction of the proteostasis network is a molecular hallmark of neurodegenerative
diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and …

Degradation of pathogenic amyloids induced by matrix metalloproteinase-9

OV Stepanenko, MI Sulatsky, EV Mikhailova… - International Journal of …, 2024 - Elsevier
Over the past decade, the greatest promise for treating severe and currently incurable
systemic and neurodegenerative diseases has turned to agents capable of effectively …

The differential solvent exposure of N-terminal residues provides “fingerprints” of alpha-synuclein fibrillar polymorphs

M Landureau, V Redeker, T Bellande, S Eyquem… - Journal of Biological …, 2021 - ASBMB
Synucleinopathies are neurodegenerative diseases characterized by the presence of
intracellular deposits containing the protein alpha-synuclein (aSYN) within patients' brains. It …

HSPB6: A lipid-dependent molecular chaperone inhibits α-synuclein aggregation

V Secco, T Tiago, R Staats, S Preet, S Chia… - Iscience, 2024 - cell.com
The process of protein misfolding and aggregation is associated with various cytotoxic
effects. Understanding how this phenomenon is regulated by the protein homeostasis …

The effects of post-translational modifications on alpha-synuclein aggregation and immune cell activation in Parkinson's disease

Z Khan, YJ Jung - Exploration of Neuroprotective Therapy, 2023 - explorationpub.com
Post-translational modifications (PTMs) of alpha-synuclein (α-syn) can alter protein
aggregation propensity to affect α-syn oligomer and fibril formation. The inflammatory …